Plasmid DNA Manufacturing Market
The plasmid DNA manufacturing market involves the production of small, circular DNA molecules that are critical components for biotechnology and genetic research. The primary customers are biopharmaceutical companies, research institutions, and drug developers. Key growth drivers include the expansion of gene and cell therapy, an increasing number of clinical trials for advanced treatments, and the rising demand for plasmid DNA as a raw material for viral vectors and mRNA vaccines.
CAGR
21.7%
Compound Annual Growth Rate
Current Value
$3.52B
Estimated 2026
Projected Value
$16.9B
By 2034